Commonwealth Equity Services’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,721
Closed -$28.9K 4475
2026
Q1
$28.9K Sell
14,721
-23,428
-61% -$55K ﹤0.01% 4237
2025
Q4
$103K Buy
38,149
+2,345
+7% +$7.7K ﹤0.01% 4109
2025
Q3
$151K Buy
35,804
+9,300
+35% +$40.9K ﹤0.01% 4018
2025
Q2
$132K Sell
26,504
-4
-0% -$17 ﹤0.01% 4014
2025
Q1
$117K Buy
26,508
+1,292
+5% +$6.06K ﹤0.01% 3968
2024
Q4
$117K Sell
25,216
-10,972
-30% -$60.3K ﹤0.01% 3880
2024
Q3
$251K Sell
36,188
-2,260
-6% -$17.7K ﹤0.01% 3503
2024
Q2
$300K Sell
38,448
-4,217
-10% -$31.2K ﹤0.01% 3288
2024
Q1
$303K Buy
42,665
+6,259
+17% +$41.4K ﹤0.01% 3268
2023
Q4
$244K Sell
36,406
-4,549
-11% -$25.6K ﹤0.01% 3344
2023
Q3
$231K Buy
40,955
+1,875
+5% +$12.5K ﹤0.01% 3258
2023
Q2
$216K Sell
39,080
-69
-0.2% -$371 ﹤0.01% 3339
2023
Q1
$244K Buy
39,149
+95
+0.2% +$530 ﹤0.01% 3139
2022
Q4
$181K Buy
39,054
+1,000
+3% +$4.93K ﹤0.01% 3269
2022
Q3
$177K Buy
38,054
+25,699
+208% +$162K ﹤0.01% 3223
2022
Q2
$73K Sell
12,355
-14,286
-54% -$159K ﹤0.01% 3426
2022
Q1
$514K Buy
26,641
+3,648
+16% +$83.7K ﹤0.01% 2498
2021
Q4
$751K Buy
22,993
+15,944
+226% +$641K ﹤0.01% 2200
2021
Q3
$289K Sell
7,049
-17,297
-71% -$628K ﹤0.01% 2970
2021
Q2
$876K Sell
24,346
-1,979
-8% -$73K ﹤0.01% 2018
2021
Q1
$1.03M Buy
26,325
+2,261
+9% +$102K ﹤0.01% 1771
2020
Q4
$970K Buy
24,064
+17,052
+243% +$783K ﹤0.01% 1669
2020
Q3
$389K Buy
+7,012
New +$371K ﹤0.01% 2162

Other funds holding GDRX

Commonwealth Equity Services's GDRX Position: Q2 2026 in Review

Commonwealth Equity Services sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 14,721 shares — an estimated $28.9K sold.

Commonwealth Equity Services first reported a position in GDRX in Q3 2020 and held it in 23 quarters. The position peaked at $1.03M in Q1 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Commonwealth Equity Services reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 14,721 GoodRx Holdings shares in Q2 2026, an estimated $28.9K.
  • Commonwealth Equity Services first reported a position in GoodRx Holdings in Q3 2020 and held it in 23 quarters.
  • Commonwealth Equity Services's GoodRx Holdings position peaked at $1.03M in Q1 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.